We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well that explains one of them - Chairman, Miroslav Reljanovic is responsible for 200k buy. So over last couple of weeks we have significant purchases from the CFO and now a £600,000 buy from the Chairman.
https://www.investegate.co.uk/ergomed-plc/ergo/director-pdmr-shareholding/201906250700142659D/?fe=1&utm_source=FE%20Investegate%20Alerts&utm_medium=Email&utm_content=Announcement%20Alert%20Mail&utm_campaign=Ergomed%20plc%20Alert
Yep, just under £1.5m in total
Did anyone else see the huge trades today?
50K @303
200K @303
240K @303
490K! This is not normal for this stock mates. We normaly trade about 30K a day....
https://seekingalpha.com/instablog/50299941-cvm4life/5319225-ergomeds-stock-tell
I agree. Something is afoot. Check out my website where I discuss Cel-Sci and Ergo: KillCVMShorts dot com/ergomed
the website link was removed killcvmshorts dot com/ergomed
Im an investor of Cel-Sci. Ergomed is the CRO for our Phase 3 trial for Multikine. I have been watching Ergomed's stock and its runup hasnt been unnoticed in the states.
I created a website to discuss Cel-Sci and ergomed's relationship. www.KillCVMShorts.com/ergomed
Another big purchase from CFO, Richard Barfield. This time just under £173k bringing the total buys from him announced this week to over £250k.
Positive RNS to start the week and a vote of confidence from the CFO with a share purchase of just under £87,000.
https://www.investegate.co.uk/ergomed-plc--ergo-/rns/pdmr-dealing/201906100700066005B/
Not that strong a recovery. Will 180p become the new temporary ceiling as it has been over last last year or so?
Live buy at 182p
Lets hope the B/O spread does not keep growing as well.
Good buying pressure . . . Should recover well.
Looks like background buying too buy large holder, price jumped to 180 ask
It should go above 200p by 10am
B/O spread seems quite large though.
Lol 175p paid, bought at 161
Can’t see a reason for 33% drop, maybe 5%!
Stephen Stamp, Chief Executive Officer of Ergomed plc said: "This year, we anticipated exceeding market expectations for revenue, allowing us to more than cover the cost of the additional investment required to deliver our strategic goals for 2020. It is unfortunate that delays and reductions in scope of a limited number of contracts has resulted in us investing ahead of the curve. The business overall is in robust health, as demonstrated by a backlog approaching £100 million, and we are confident 2018 will provide a solid foundation for future growth."
Potential bounce back. Agreed looks over done. Never of course 100% for a bounce back......
In for the bounce back, could finish 200p
Looks overdone
Michael Von Forstner appointed as Head of Risk Management and Pharmacoepidemiology. 'His skills will broaden Ergomed's premium service offering within PrimeVigilance, and build new revenue streams in pharmacoepidemiology and risk minimisation services, meeting high demand for these services.' https://investegate.co.uk/ergomed-plc--ergo-/rns/key-hire-in-pharmacoepidemiology-services/201805250700082474P/ http://www.terrapinn.com/conference/world-drug-safety-congress-europe/speaker-michaelvon-FORSTNER.stm
They were sold in an orderly way and with over 15m shares he still holds just under 34% of the Company. I'm not sure that I have any issue at all with him selling some stock and taking some profit. He has built the company from scratch, seen it through a successful IPO and every year since has delivered strong growth in revenue and contracts secured. The latest trading statement suggests that this has been yet another year of solid growth. It's the CEO's who cash in while their companies are underperforming that I have an issue with! Good to see Chairman Peter George making a substantial purchase - just under �1m, not to be sneezed at!
Miroslav Reljanovic sold 2.5m shares today. Not really offset by Peter George's buy of 500k.
Strong update from Ergomed this morning:- - new service contracts in 2017 �54m up 29% - net service revenues �39m up 35% - total revenues �47m up 21% - order backlog up to �88m Good stuff "According to Hamill, Ergomed�s drugs safety unit alone is worth as much as the whole business, which is currently valued at �84mln" http://www.proactiveinvestors.co.uk/companies/news/190625
"PrimeVigilance's CEO, Jan Petracek, will be presenting the results from its successful pilot project demonstrating how robotic process automation of selected pharmacovigilance systems can increase efficiency by up to 400 times, increasing speed, reducing cost and improving accuracy. PrimeVigilance is working on the early deployment of robots in its operations." https://investegate.co.uk/ergomed-plc--ergo-/rns/ergomed-s-primevigilance-hosts-automation-seminar/201712040700052205Y/